Anatomy & Physiology Study Guide
21

The Endocrine System

Slide deck, chapter 2135 slidesChapter outline and sourcesPractice questions

  1. 21.1

    Hormone classes predict storage, transport and half-life

    • Peptides and proteins are made as preprohormones, cut in the ER and Golgi, stored in granules and released by Ca2+-triggered exocytosis; they travel free, so half-lives are short.
    • Steroids derive from cholesterol, are not stored but made on demand, and ride on carrier proteins, which lengthens half-life well beyond that of peptides.
    • Amines split in two: catecholamines are hydrophilic and stored in granules; thyroid hormones are lipophilic, heavily protein bound and long lived.
    • Eicosanoids are made from membrane arachidonic acid and act locally as paracrine or autocrine signals, so they never reach a plasma pool of note.
    • Rule of thumb: water-soluble hormones bind surface receptors; lipid-soluble hormones cross the membrane and need carriers in plasma.

    Outcome

    1. 1Classify hormones as peptide/protein, steroid, amine (catecholamine or thyroid) or eicosanoid and predict storage, transport and half-life from the class.
  2. 21.1

    Membrane receptor cascades with a named hormone each

    • Gs raises adenylyl cyclase, cAMP and protein kinase A (ACTH, glucagon, TSH, PTH); Gi lowers cAMP (somatostatin).
    • Gq activates phospholipase C to make IP3, which frees Ca2+ from the ER, and DAG, which activates protein kinase C (TRH, GnRH, oxytocin).
    • Receptor tyrosine kinases (insulin, IGF-1) autophosphorylate and recruit IRS proteins, feeding PI3K-Akt and Ras-MAPK.
    • Cytokine receptors (GH, prolactin, leptin) lack kinase activity and recruit JAK2, which phosphorylates STAT dimers that enter the nucleus.
    • Guanylyl cyclase receptors raise cGMP (ANP, BNP); each step amplifies the signal and phosphodiesterases and phosphatases end it.

    Outcome

    1. 2Compare the signalling cascades of Gs, Gi, Gq, receptor tyrosine kinase, cytokine (JAK-STAT) and guanylyl cyclase receptors with a named hormone for each.
  3. 21.1

    Nuclear receptors and why they act slowly

    • Steroid receptors (glucocorticoid, mineralocorticoid, sex steroids) wait in the cytoplasm bound to heat-shock proteins until ligand arrives, then dimerize and enter the nucleus.
    • Thyroid hormone, vitamin D and retinoid receptors already sit in the nucleus and pair with RXR before binding response elements.
    • The ligand-receptor complex binds hormone response elements and recruits co-activators or co-repressors to change transcription.
    • The effect needs new mRNA and protein, so onset takes hours, whereas second-messenger signalling at the membrane acts in seconds to minutes.

    Outcome

    1. 3Explain how nuclear receptors for steroid, thyroid, vitamin D and retinoid hormones alter gene transcription and why the onset is slower than for membrane receptors.
  4. 21.1

    Binding proteins, clearance and free hormone

    • Only free hormone is active; bound hormone is a reservoir that cannot cross capillaries until it dissociates.
    • Cortisol is 90 to 95 percent bound, mainly to CBG, giving a half-life of 60 to 90 minutes; aldosterone is only about 60 percent bound and lasts about 20 minutes.
    • More than 99 percent of thyroid hormone is bound, so its half-life is long and a change in TBG moves total hormone without moving free hormone.
    • Clearance is by receptor-mediated internalization, enzymatic degradation, hepatic conjugation and renal excretion.
    • Read a total hormone level only alongside the binding protein state and the matching feedback hormone.

    Outcome

    1. 4Describe how binding proteins, clearance and metabolism set free-hormone concentration and plasma half-life.
  5. 21.1

    Feedback loops and secretion patterns

    • Negative feedback is the rule: cortisol suppresses CRH and ACTH. Positive feedback is rare, as in oxytocin during labor.
    • Long loops are target hormone acting on pituitary or hypothalamus, short loops are pituitary hormone acting on hypothalamus, ultrashort loops are local effects on the releasing cell.
    • Pulsatile secretion (GnRH, GH) carries information in its rhythm; circadian secretion (cortisol peaking near waking) follows the day.
    • Stimulus-driven secretion, such as insulin after glucose, follows the level of the regulated variable.

    Outcome

    1. 5Distinguish negative feedback, positive feedback, long/short/ultrashort loops and pulsatile versus circadian secretion with one example each.
  6. 21.1

    Receptor regulation and hormone interactions

    • Sustained high ligand lowers receptor number or sensitivity (down-regulation, desensitization), as with insulin receptors in obesity.
    • Continuous rather than pulsatile GnRH desensitizes gonadotrophs, which is why GnRH agonists suppress the gonadal axis.
    • Permissive interactions need one hormone to allow another to act (cortisol allows catecholamine vascular tone).
    • Synergism adds effects beyond the sum (GH plus cortisol raising glucose); antagonism opposes them (insulin versus glucagon).

    Outcome

    1. 6Explain receptor up- and down-regulation, desensitization and permissive, synergistic and antagonistic hormone interactions.
  7. 21.2

    Pituitary origin, parts and portal blood supply

    • The adenohypophysis comes from Rathke pouch, an upgrowth of oral ectoderm; the neurohypophysis is a downgrowth of diencephalic neuroectoderm.
    • Adenohypophysis parts are pars distalis, pars tuberalis and pars intermedia; neurohypophysis parts are pars nervosa, infundibulum and median eminence.
    • Superior hypophyseal arteries feed a primary capillary plexus in the median eminence; portal veins carry releasing hormones to a secondary plexus in the pars distalis.
    • Inferior hypophyseal arteries supply the pars nervosa. The gland sits in the sella turcica below the optic chiasm, so a mass gives bitemporal hemianopsia.

    Outcome

    1. 7Describe the embryologic origin, parts and blood supply of the pituitary, including the hypophyseal portal system.
  8. 21.2

    Hypothalamic releasing and inhibiting hormones

    • TRH acts on thyrotrophs (TSH, and prolactin); CRH on corticotrophs (POMC to ACTH); GnRH on gonadotrophs (LH, FSH); GHRH on somatotrophs (GH).
    • Dopamine inhibits prolactin; somatostatin inhibits GH and TSH.
    • Parvocellular neurons release into the portal system, and GnRH must arrive in pulses (about hourly) for gonadotrophs to respond.
    • Prolactin is the one anterior hormone under tonic inhibition, so a stalk lesion raises prolactin and lowers the others.
    • POMC is also cleaved to beta-lipotropin and MSH peptides, which is why excess ACTH darkens skin.

    Outcome

    1. 8Name each hypothalamic releasing and inhibiting hormone with its anterior pituitary target cell and product.
  9. 21.2

    Growth hormone, IGF-1 and its disorders

    • GH acts through JAK2-STAT5, mainly in liver, to make IGF-1; IGF-1 feeds back and stimulates somatostatin.
    • Metabolic effects: lipolysis, reduced glucose uptake (anti-insulin), protein anabolism, and growth of cartilage at epiphyseal plates.
    • Secretion is pulsatile with peaks in deep sleep; hypoglycemia, exercise, ghrelin and stress raise it; hyperglycemia and IGF-1 lower it.
    • Excess before plate closure gives gigantism; after closure it gives acromegaly with acral growth, prognathism, glucose intolerance and headache.
    • Childhood deficiency gives proportionate short stature; Laron dwarfism is GH-receptor resistance with high GH and low IGF-1.

    Outcome

    1. 9Explain growth hormone secretion, IGF-1 mediation and metabolic actions, and predict acromegaly and pituitary dwarfism.
  10. 21.2

    ADH and oxytocin from the posterior pituitary

    • Both nonapeptides are made in supraoptic and paraventricular nuclei, travel with neurophysin down the hypothalamo-hypophyseal tract and are released from axon terminals in the pars nervosa.
    • ADH is suppressed below a plasma osmolality of about 280 mOsm/kg and rises above it (a 1 percent change is enough); blood volume must fall about 10 percent before ADH rises appreciably.
    • V2 receptors insert aquaporin-2 in collecting-duct principal cells; V1 receptors constrict vessels.
    • Central diabetes insipidus lacks ADH; nephrogenic lacks the response. Desmopressin corrects the first only. SIADH gives euvolemic hyponatremia with concentrated urine.
    • Oxytocin acts through Gq on myometrium (the Ferguson reflex, positive feedback in labor) and on myoepithelial cells for milk let-down.

    Outcome

    1. 10Explain the synthesis, transport and release of ADH and oxytocin from the posterior pituitary and the stimuli that control each.
  11. 21.2

    Stimulation and suppression test logic

    • Read the target-gland hormone with the pituitary hormone: low T4 with high TSH is primary failure, low T4 with low TSH is central.
    • Stimulation tests prove deficiency by failing to raise the hormone (insulin tolerance or glucagon for GH and ACTH, cosyntropin for adrenal reserve).
    • Suppression tests prove autonomy by failing to lower it: an oral glucose load fails to suppress GH in acromegaly.
    • Low-dose dexamethasone should suppress ACTH and cortisol; failure supports Cushing syndrome, and high-dose suppression separates a pituitary source from an ectopic one.

    Outcome

    1. 11Interpret stimulation and suppression test logic for pituitary axes, including a dexamethasone suppression and an oral glucose GH suppression.
  12. 21.2

    Pituitary histology

    • Pars distalis is cords of cells around sinusoids: acidophils (somatotrophs, lactotrophs) stain pink, basophils (corticotrophs, thyrotrophs, gonadotrophs) blue-purple, chromophobes faintly.
    • Pars nervosa is pale and fibrous, with unmyelinated axons, pituicytes (glial support cells) and Herring bodies, which are swellings full of stored oxytocin or ADH.
    • Pars intermedia can show colloid-filled cysts; pars tuberalis wraps the stalk.

    Outcome

    1. 12Identify acidophils, basophils, chromophobes, Herring bodies and pituicytes on pituitary slides.
  13. 21.3

    Thyroid relations, supply and development

    • Two lobes joined by an isthmus over tracheal rings 2-3 sit anterior to the trachea, deep to sternothyroid and sternohyoid.
    • The superior thyroid artery comes from the external carotid and the inferior thyroid artery from the thyrocervical trunk; a thyroid ima artery is an occasional variant.
    • The recurrent laryngeal nerve runs near the inferior thyroid artery and the external branch of the superior laryngeal nerve near the superior artery, so both are at risk in thyroidectomy.
    • The gland descends from the foramen cecum as the thyroglossal duct; persistence gives a thyroglossal cyst and a pyramidal lobe is a remnant.

    Outcome

    1. 13Describe the gross relations, blood supply and embryologic origin of the thyroid, including the thyroglossal duct tract.
  14. 21.3

    Thyroid histology and follicle height

    • Follicles are lined by simple cuboidal follicular cells around colloid rich in thyroglobulin.
    • Active follicles have tall columnar cells and scalloped, depleted colloid; resting follicles have flat cells and abundant colloid.
    • Parafollicular C cells are pale cells between follicles or in the basal epithelium and make calcitonin.
    • Fenestrated capillaries wrap the follicles and let hormone enter blood.

    Outcome

    1. 14Identify follicles, colloid, follicular cells and parafollicular C cells on a thyroid slide and relate follicle height to activity.
  15. 21.3

    Steps of thyroid hormone synthesis and their blockers

    • The Na+/I- symporter traps iodide against its gradient; perchlorate and thiocyanate compete for it.
    • Pendrin moves iodide into the lumen, where thyroid peroxidase oxidizes it and iodinates tyrosines of thyroglobulin to make MIT and DIT.
    • TPO also couples DIT with DIT to form T4 and MIT with DIT to form T3; methimazole and PTU inhibit TPO.
    • TSH drives colloid endocytosis, proteolysis and release of T4 and T3; excess iodide transiently blocks release (Wolff-Chaikoff effect).
    • Output is mainly T4 at about 14 to 1 (roughly 93 percent T4, 7 percent T3), and the adult iodine RDA is 150 micrograms per day.

    Outcome

    1. 15Sequence the steps of thyroid hormone synthesis from iodide trapping to secretion and name the enzyme and drug blocking each step.
  16. 21.3

    T4 to T3, transport and actions

    • More than 99 percent of thyroid hormone is bound, mainly to TBG; free hormone acts.
    • T4 is a prohormone: deiodinases 1 and 2 make active T3 in tissues (about four-fifths of circulating T3), while deiodinase 3 makes inactive reverse T3.
    • T3 binds nuclear receptors paired with RXR; it raises Na+/K+-ATPase, basal metabolic rate, heat production, beta-receptor expression and cardiac output.
    • It is required for growth and CNS development, so untreated congenital hypothyroidism causes cretinism.
    • It raises glycolysis, gluconeogenesis, lipolysis and LDL receptor clearance, so hypothyroidism raises LDL.

    Outcome

    1. 16Explain peripheral T4-to-T3 conversion, transport proteins and the mechanism and metabolic effects of thyroid hormone.
  17. 21.3

    Thyroid laboratory patterns

    • Primary hypothyroidism: low free T4 with high TSH. Central hypothyroidism: low free T4 with low or inappropriately normal TSH.
    • Primary hyperthyroidism: high free T4 with suppressed TSH. A TSH-secreting source gives high T4 with non-suppressed TSH.
    • Graves disease: antibodies mimic TSH, causing a diffuse goiter, exophthalmos and low TSH.
    • Hashimoto thyroiditis: anti-TPO and antithyroglobulin antibodies with lymphocytic infiltrate, ending in hypothyroidism with high TSH.
    • Iodine deficiency lowers hormone output, TSH stays high and a goiter forms.

    Outcome

    1. 17Predict laboratory patterns (TSH, free T4) in primary and central hypo- and hyperthyroidism and in Graves and Hashimoto disease.
  18. 21.4

    Parathyroid location, supply and histology

    • Usually four glands lie on the posterior thyroid surface, separated from it by a connective tissue capsule; the superior pair come from pouch IV and the inferior pair from pouch III.
    • Pouch III also forms the thymus, so inferior glands can descend ectopically into the mediastinum.
    • Blood comes mainly from the inferior thyroid artery, so thyroidectomy can devascularize them.
    • Chief cells are small, dark-staining and secrete PTH; oxyphil cells are larger, eosinophilic, mitochondria rich and function unclear; adipocytes increase with age.

    Outcome

    1. 18Locate the four parathyroid glands and their blood supply and identify chief and oxyphil cells on a slide.
  19. 21.4

    Calcium-sensing receptor control of PTH

    • The calcium-sensing receptor on chief cells is a Gq receptor that is activated by high Ca2+.
    • Falling Ca2+ takes the brake off, so PTH rises within minutes; rising Ca2+ suppresses it, closing a negative feedback loop.
    • Severe magnesium deficiency also impairs PTH release.
    • Total serum calcium is about 9 to 10.5 mg/dL and ionized about 4.7 to 5.2 mg/dL, so a small fall in ionized Ca2+ is a strong secretory signal.

    Outcome

    1. 19Explain the regulation of PTH secretion by extracellular Ca2+ through the calcium-sensing receptor.
  20. 21.4

    PTH actions on bone, kidney and gut

    • Bone: PTH acts on osteoblasts, which express RANKL and activate osteoclasts, releasing Ca2+ and phosphate; sustained PTH is catabolic, intermittent dosing is anabolic.
    • Kidney: more Ca2+ reabsorption in the distal tubule, less phosphate reabsorption in the proximal tubule, and stimulation of 1-alpha-hydroxylase.
    • Gut: the effect is indirect, through calcitriol made in the kidney.
    • Net result: serum Ca2+ rises and phosphate falls; PTH acts through Gs and cAMP.

    Outcome

    1. 20Describe PTH actions on bone, kidney and, indirectly, intestine.
  21. 21.4

    Vitamin D activation and actions

    • UVB converts 7-dehydrocholesterol in skin to cholecalciferol; diet adds D2 and D3.
    • The liver 25-hydroxylates to calcidiol, the storage form measured clinically; the kidney 1-alpha-hydroxylates to calcitriol, the active hormone.
    • Renal 1-alpha-hydroxylase is stimulated by PTH, low phosphate and low Ca2+.
    • Calcitriol raises intestinal Ca2+ and phosphate absorption, supports bone mineralization and suppresses PTH.
    • Deficiency causes rickets in children and osteomalacia in adults.

    Outcome

    1. 21Trace vitamin D from skin or diet through hepatic 25-hydroxylation and renal 1-alpha-hydroxylation to calcitriol and describe its actions.
  22. 21.4

    Integrating calcium control and hyperparathyroidism

    • Hypocalcemia raises PTH and calcitriol and gives tetany (Chvostek and Trousseau signs); hypercalcemia raises calcitonin from C cells, a minor adult role.
    • FGF23 from osteocytes increases phosphate excretion and suppresses 1-alpha-hydroxylase.
    • Plasma calcium is about 50 percent ionized, about 40 percent protein bound and about 10 percent complexed; acidosis frees calcium from protein and alkalosis binds more.
    • Primary hyperparathyroidism (adenoma): high Ca2+, low phosphate, high PTH. Secondary (renal failure): low Ca2+, high phosphate, high PTH.
    • Chvostek sign (facial twitch on tapping the facial nerve) occurs in most acute hypocalcemia but also in up to 10 percent of healthy people; Trousseau sign is carpal spasm after 3 minutes of cuff use.

    Outcome

    1. 22Integrate PTH, calcitriol, calcitonin and FGF23 into a response to hypo- and hypercalcemia and interpret primary and secondary hyperparathyroidism.
  23. 21.5

    Adrenal zones and what each secretes

    • Cortex from outside in: zona glomerulosa (rounded clusters, aldosterone), zona fasciculata (long cords of lipid-rich cells, cortisol), zona reticularis (anastomosing cords, DHEA and androgens).
    • The medulla is made of chromaffin cells and secretes mainly epinephrine.
    • Salt, sugar, sex: the order from outside inward matches mineralocorticoid, glucocorticoid, androgen.
    • Each gland drains by one vein, right into the IVC and left into the left renal vein; preganglionic sympathetic fibers directly innervate the medulla.

    Outcome

    1. 23Identify the three cortical zones and the medulla on an adrenal slide and give the principal hormone of each.
  24. 21.5

    Steroidogenesis at overview level

    • StAR carries cholesterol into mitochondria, the rate-limiting step, and CYP11A1 cleaves it to pregnenolone.
    • Glomerulosa lacks 17-alpha-hydroxylase and has aldosterone synthase; fasciculata has 17-alpha-hydroxylase, 21-hydroxylase and 11-beta-hydroxylase for cortisol.
    • Reticularis makes DHEA and androstenedione through 17,20-lyase; peripheral tissues convert them to testosterone and estrogens.
    • 21-Hydroxylase deficiency blocks cortisol and aldosterone, ACTH rises, and steroid precursors are shunted to androgens.
    • Renal 11-beta-HSD2 inactivates cortisol, protecting the mineralocorticoid receptor.

    Outcome

    1. 24Outline steroidogenesis from cholesterol to aldosterone, cortisol and androgens, naming zone-specific enzymes at overview level.
  25. 21.5

    Aldosterone regulation and action

    • Angiotensin II (AT1, Gq) and hyperkalemia stimulate aldosterone release from glomerulosa; ACTH acts weakly; ANP inhibits it.
    • In principal cells of the late distal tubule and collecting duct it raises ENaC and Na+/K+-ATPase activity and K+ secretion.
    • Intercalated cells secrete H+, so excess aldosterone gives alkalosis.
    • Excess (Conn syndrome): hypertension, hypokalemia, metabolic alkalosis and low renin. Deficiency: hypotension, hyponatremia and hyperkalemia.

    Outcome

    1. 25Explain regulation of aldosterone by the renin-angiotensin system and potassium, and its effects on the collecting duct.
  26. 21.5

    HPA axis and the actions of cortisol

    • CRH drives ACTH drives cortisol; cortisol inhibits both CRH and ACTH. Secretion peaks near waking and is lowest at night.
    • Metabolic actions: gluconeogenesis, protein catabolism, lipolysis with central fat redistribution and insulin resistance.
    • Anti-inflammatory actions include inhibition of phospholipase A2 through lipocortin and fewer cytokines, lymphocytes and eosinophils, with higher neutrophil counts.
    • It is permissive for catecholamine vascular tone, and fetal cortisol promotes surfactant and organ maturation.

    Outcome

    1. 26Explain the HPA axis, circadian rhythm and the metabolic, anti-inflammatory and permissive actions of cortisol.
  27. 21.5

    Catecholamine synthesis, release and receptors

    • Tyrosine goes to L-DOPA (tyrosine hydroxylase, rate-limiting), to dopamine, to norepinephrine, then to epinephrine by PNMT, which cortisol from cortical blood induces.
    • Preganglionic sympathetic ACh acts on nicotinic receptors to trigger release, which is about 80 percent epinephrine and 20 percent norepinephrine.
    • Alpha-1 vasoconstricts; beta-1 raises heart rate and contractility; beta-2 relaxes bronchi and muscle vessels and drives glycogenolysis and lipolysis.
    • MAO and COMT break them down to metanephrines and VMA, the basis of pheochromocytoma testing.

    Outcome

    1. 27Describe catecholamine synthesis, adrenal medullary release and receptor-specific effects of epinephrine.
  28. 21.5

    Adrenal disorders mapped to pathways

    • Cushing syndrome: cortisol excess with central obesity, striae, proximal weakness, hypertension, hyperglycemia; exogenous steroids are the commonest cause, Cushing disease is a pituitary ACTH source.
    • Addison disease: autoimmune destruction with low cortisol and aldosterone, high ACTH and hyperpigmentation, hypotension, hyponatremia and hyperkalemia.
    • 21-Hydroxylase CAH: low cortisol, high ACTH, high 17-OH-progesterone and androgen excess.
    • Conn syndrome: aldosterone excess with low renin and low K+. Pheochromocytoma: episodic hypertension, headache, sweating and palpitations with raised metanephrines.

    Outcome

    1. 28Relate Cushing syndrome, Addison disease, congenital adrenal hyperplasia, Conn syndrome and pheochromocytoma to the pathways they disturb.
  29. 21.5

    Alarm, resistance and exhaustion

    • Alarm (fight-or-flight): sympathetic activity and medullary catecholamines raise heart rate, blood glucose and flow to muscle.
    • Resistance: sustained cortisol, GH, glucagon, ADH and aldosterone defend glucose and fluid volume.
    • Exhaustion: depleted reserves and prolonged cortisol exposure bring immunosuppression, hypertension, hyperglycemia and mood disturbance.

    Outcome

    1. 29Sequence the alarm, resistance and exhaustion phases of the stress response.
  30. 21.6

    Islet cell types and positions

    • Islets are pale clusters among darker exocrine acini on H&E, with dense fenestrated capillaries.
    • Beta cells are the majority of islet cells (roughly 60 to 75 percent depending on the study) and make insulin and amylin; they sit toward the center of the islet.
    • Alpha cells (roughly 20 to 30 percent) make glucagon and lie toward the periphery; delta cells, a few percent, make somatostatin.
    • PP (F) cells, about 1 percent, make pancreatic polypeptide; islets are only 1 to 2 percent of pancreatic mass yet number in the millions.

    Outcome

    1. 30Identify alpha, beta and delta cells in an islet and give the hormone and location (islet center or periphery) of each.
  31. 21.6

    Insulin synthesis and glucose-stimulated release

    • Preproinsulin becomes proinsulin in the ER; the Golgi cleaves it to insulin plus C-peptide in equal amounts, so C-peptide marks endogenous secretion.
    • Glucose enters beta cells through GLUT2, and glucokinase sets the sensing rate; ATP rises and closes K-ATP channels.
    • Depolarization opens voltage-gated Ca2+ channels, and Ca2+ triggers granule exocytosis.
    • Sulfonylureas close K-ATP channels directly; GLP-1 and GIP amplify release through cAMP; secretion is biphasic.

    Outcome

    1. 31Describe insulin synthesis from preproinsulin to proinsulin and C-peptide and the glucose-stimulated pathway of release.
  32. 21.6

    Insulin receptor signalling and target tissues

    • The tyrosine kinase receptor phosphorylates IRS proteins, activating PI3K-Akt (metabolic) and Ras-MAPK (mitogenic) arms.
    • Muscle and fat: GLUT4 translocation, glycogen and protein synthesis, lipogenesis and inhibition of hormone-sensitive lipase.
    • Liver glucose uptake is GLUT2 and insulin independent; insulin raises glycogen synthesis and lipogenesis and suppresses gluconeogenesis and ketogenesis.
    • Insulin also drives K+ into cells through Na+/K+-ATPase, which treats hyperkalemia; its half-life is about 4 to 6 minutes.

    Outcome

    1. 32Explain insulin receptor signalling and the effects on liver, muscle and adipose tissue, including GLUT4 recruitment.
  33. 21.6

    Glucagon and counter-regulation

    • Glucagon acts through Gs-cAMP-PKA in liver: glycogenolysis, gluconeogenesis and ketogenesis, with little effect on muscle.
    • Release rises with hypoglycemia, amino acids and sympathetic input; insulin and somatostatin suppress it.
    • In hypoglycemia insulin falls first, glucagon and epinephrine rise next, and cortisol and GH act over hours.

    Outcome

    1. 33Explain glucagon actions and the counter-regulatory response to hypoglycemia.
  34. 21.6

    Type 1, type 2 diabetes and ketoacidosis

    • Type 1: autoimmune beta-cell destruction (anti-GAD, islet-cell antibodies), absolute insulin deficiency and ketosis.
    • Type 2: insulin resistance with relative deficiency; plasma insulin may be several-fold above normal; ketoacidosis is rare but a hyperosmolar state occurs.
    • Diabetic ketoacidosis: hyperglycemia, ketonemia, anion-gap acidosis, osmotic diuresis and total body K+ depletion even if serum K+ is normal or high.
    • Chronic complications come from glycation and polyol injury: retinopathy, nephropathy, neuropathy and macrovascular disease.
    • Diagnosis: fasting glucose 126 mg/dL or more or A1C 6.5 percent or more (random or 2-hour OGTT glucose 200 or more); prediabetes is fasting 100-125 mg/dL or A1C 5.7-6.4 percent.

    Outcome

    1. 34Compare type 1 diabetes, type 2 diabetes and diabetic ketoacidosis in mechanism, laboratory findings and acute and chronic complications.
  35. 21.6

    Hormones of other endocrine tissues

    • Pineal melatonin is made from serotonin and released at night; light via the suprachiasmatic nucleus inhibits it.
    • Gonads make testosterone and inhibin (testis) and estrogen, progesterone and inhibin (ovary); the placenta makes hCG, progesterone, estrogen and placental lactogen.
    • Gut: gastrin, secretin, CCK, GIP, GLP-1 and ghrelin. Kidney: erythropoietin, calcitriol and renin.
    • Heart: ANP and BNP. Adipose: leptin and adiponectin. Thymus: thymosin.

    Outcome

    1. 35Summarize the hormones of the pineal, gonads, placenta, gut, kidney, heart and adipose tissue and their stimuli.